SB 384 amends Michigan law to allow county jails with medically assisted treatment programs to have dispensing prescribers delegate the delivery of specific prescription drugs directly to inmates. It applies to inmates currently in jail or those being released, permitting delivery of up to a 30-day supply of medication for medically assisted treatment. The bill requires delivery to follow written protocols and specifies that only drugs associated with these treatment programs can be delivered this way. This change streamlines medication access without requiring on-site pharmacies in participating jails.
HB 4683 requires Michigan health insurers to cover medically necessary mental health and substance use disorder treatments (including inpatient, intermediate, and outpatient care) without restrictive prior authorization practices. It mandates that insurers use clinical review criteria aligned with generally accepted medical standards, rather than arbitrary rules, when evaluating these services. The bill also prohibits insurers from making mental health coverage terms less favorable than those for other medical treatments. This directly affects health insurers operating in Michigan and patients seeking mental health or substance use disorder care through their insurance plans.
SB 38 amends Michigan's Social Welfare Act to explicitly include perinatal and gynecological services in Medicaid coverage for eligible individuals. The bill updates Section 109 (MCL 400.109) to require the department to provide guidelines ensuring these services are covered under the state's medical assistance plan. This directly affects Medicaid recipients in Michigan who need care related to pregnancy, childbirth, postpartum recovery, or women's health conditions. The change ensures these services are formally recognized in coverage rules, aligning with existing Medicaid requirements for other medical services.
SB 551 requires Michigan's Medicaid program to cover non-opioid prescription drugs used for pain management without prior authorization, adding them to the preferred drug list within 90 days. It directly affects Medicaid patients seeking pain treatment and healthcare providers prescribing these medications. The bill prevents discriminatory coverage by ensuring non-opioid pain drugs aren't subject to stricter approval rules than opioid alternatives. This policy change streamlines access to non-opioid options under the medical assistance program.
SB 552 requires Michigan health insurers to cover non-opioid pain medications prescribed for pain treatment, directly affecting insurers and policyholders. The bill mandates that insurers include such drugs on preferred drug lists within 90 days of FDA approval, prohibits discouraging coverage relative to opioids (e.g., labeling non-opioid drugs as "nonpreferred" when opioids are preferred), and prevents overly restrictive prior authorization for non-opioid options. It does not require insurers to cover specific drugs but ensures equal treatment compared to opioid alternatives in formularies. The law applies to all health insurance policies covering prescription drugs in Michigan.
SB 400 prohibits Michigan health insurers from requiring prior authorization for medications treating opioid use disorder or alcohol use disorder. This directly affects health insurance companies and patients seeking these specific treatments, removing a common administrative barrier. The bill amends Michigan’s Insurance Code to explicitly ban prior authorization requirements for these medications, using the existing definition of "prior authorization" from Section 2212e. The law ensures faster access to evidence-based treatment without insurer delays.
SB 401 requires doctors to co-prescribe naloxone - a medication that reverses opioid overdoses - whenever they prescribe opioid painkillers. This directly affects healthcare providers who prescribe opioids and their patients, mandating that naloxone be provided at the same time as the opioid prescription. The bill amends existing law to make this co-prescribing a standard requirement, not an option. It aims to reduce opioid overdose deaths by ensuring patients have immediate access to naloxone when prescribed opioids. The bill passed the legislature with strong support on July 1, 2025.
SB 403 requires Michigan pharmacists to dispense certain medications used to treat addiction without unnecessary delay. This directly affects pharmacists who handle these medications and patients seeking treatment for substance use disorders. The bill amends Michigan's Pharmacy Act (MCL 333.1101 et seq.) by adding a new provision that eliminates administrative barriers causing delays in providing these critical medications. It establishes a clear requirement for prompt dispensing while maintaining pharmacists' existing professional responsibilities.
SB 628 requires Michigan's medical assistance program (Medicaid) to cover syringe service programs, which provide clean needles, disposal containers, and other harm reduction supplies to people who inject drugs. This directly affects individuals who use injection drugs by expanding access to safer equipment, and it affects the state's Medicaid program by mandating coverage for these services. The bill defines "syringe service programs" as harm reduction initiatives offering supplies like needles, cookers, and sharps disposal containers. It does not change eligibility for Medicaid but ensures these specific harm reduction services are funded under existing medical assistance.
HB 5053 requires medical control authorities to ensure all emergency medical services (EMS) agencies and personnel provide epinephrine or auto-injectors and are trained to recognize anaphylaxis, administer epinephrine, and properly dispose of devices. This directly affects EMS providers who deliver prehospital care across Michigan, mandating specific equipment availability and training protocols. The bill amends existing public health code requirements to strengthen emergency response capabilities for severe allergic reactions, with no changes to opioid antagonist or defibrillator requirements.